When a Pathological Forearm Fracture Led to Explore the Neck: About a Case

  • Cyrille BuissetEmail author
  • Léa Demarquet
  • Marie Raynal
  • Hélène Busby
  • Claire Nominé-Criqui
  • Laurent Brunaud
Case Reports


The majority of patients with parathyroid carcinoma (PC) have significant clinical signs and simultaneous symptoms related to the unregulated hypersecretion of parathyroid hormone (PTH) by the tumor. The aim of this case was to report a patient presenting an isolated bone fracture leading to the diagnosis of PC. A 20-years-old female patient presenting a fracture of both bones of the forearm following a fall from her own height. Imageries showed diffuse bone demineralization. Biology revealed malignant hypercalcemia at 4.1 mmol/L and PTH at 1331 pg/mL. Bone densitometry showed severe osteoporosis with a femoral and lumbar T-score < − 3DS. Imageries showed a right parathyroid mass of 32 mm. An one-piece excision of the pathological gland, right thyroid lobectomy and ipsilateral central lymph node dissection were performed. Postoperatively, the patient presented a hungry bone syndrome with severe hypocalcemia and required substitutive treatment. PTH on day 1 was normal. Pathology analysis found a PC with Ki67 at 3%, lymph node removal was negative. Complete one-piece surgical excision is the only potentially curative treatment for PC. Preoperative suspicion and intraoperative recognition of malignant features is important in order to propose an appropriate compartmental surgery, which can provide the lowest possible recurrence rate.


Parathyroid carcinoma Pathological fracture Primary hyperparathyroidism Surgery 


Author Contributuions

All authors should have made substantial contributions to all of: (1) the conception and design of the study, or acquisition of data, or analysis and interpretation of data, (2) drafting the article or revising it critically for important intellectual content, (3) final approval of the version to be submitted.

Compliance with Ethical Standards

Conflict of interest

All authors declare that they have no conflict of interest.


  1. 1.
    Sharretts JM, Kebebew E, Simonds WF. Parathyroid cancer. Semin Oncol. 2010;37(6):580–90.CrossRefGoogle Scholar
  2. 2.
    Wei CH, Harari A. Parathyroid carcinoma: update and guidelines for management. Curr Treat Options Oncol. 2012;13(1):11–23.CrossRefGoogle Scholar
  3. 3.
    Bae JH, Choi HJ, Lee Y, Moon MK, Park YJ, Shin CS, et al. Preoperative predictive factors for parathyroid carcinoma in patients with primary hyperparathyroidism. J Korean Med Sci. 2012;27(8):890.CrossRefGoogle Scholar
  4. 4.
    Sidhu PS, Talat N, Patel P, Mulholland NJ, Schulte K-M. Ultrasound features of malignancy in the preoperative diagnosis of parathyroid cancer: a retrospective analysis of parathyroid tumours larger than 15 mm. Eur Radiol. 2011;21(9):1865–73.CrossRefGoogle Scholar
  5. 5.
    Fang SH, Lal G. Parathyroid cancer. Endocr Pract. 2011;17(Suppl 1):36–43.CrossRefGoogle Scholar
  6. 6.
    Wilkins BJ, Lewis JS. Non-functional parathyroid carcinoma: a review of the literature and report of a case requiring extensive surgery. Head Neck Pathol. 2009;3(2):140–9.CrossRefGoogle Scholar
  7. 7.
    Sandelin K, Auer G, Bondeson L, Grimelius L, Farnebo LO. Prognostic factors in parathyroid cancer: a review of 95 cases. World J Surg. 1992;16(4):724–31.CrossRefGoogle Scholar
  8. 8.
    Kebebew E, Arici C, Duh Q, Clark OH. Localization and reoperation results for persistent and recurrent parathyroid carcinoma. Arch Surg. 2001;136(8):878–85.CrossRefGoogle Scholar
  9. 9.
    Harari A. Parathyroid carcinoma. In: Clark OH, Duh QY, Kebebew E, Gosnell JE, Shen WT, editors. Textbook of endocrine surgery. 3rd ed. Philadelphia: Jaypee Brothers Medical Publishers; 2016.Google Scholar
  10. 10.
    Busaidy NL, Jimenez C, Habra MA, Schultz PN, El-Naggar AK, Clayman GL, et al. Parathyroid carcinoma: a 22-year experience. Head Neck. 2004;26(8):716–26.CrossRefGoogle Scholar
  11. 11.
    Shaha AR, Shah JP. Parathyroid carcinoma: a diagnostic and therapeutic challenge. Cancer. 1999;86:378–80.CrossRefGoogle Scholar
  12. 12.
    Harari A, Waring A, Fernandez-Ranvier G, Hwang J, Suh I, Mitmaker E, et al. Parathyroid carcinoma: a 43-year outcome and survival analysis. J Clin Endocrinol Metab. 2011;96(12):3679–86.CrossRefGoogle Scholar
  13. 13.
    Rubin MR, Bilezikian JP, Birken S, Silverberg SJ. Human chorionic gonadotropin measurements in parathyroid carcinoma. Eur J Endocrinol. 2008;159(4):469–74.CrossRefGoogle Scholar
  14. 14.
    Cavalier E, Betea D, Schleck M-L, Gadisseur R, Vroonen L, Delanaye P, et al. The third/second generation PTH assay ratio as a marker for parathyroid carcinoma: evaluation using an automated platform. J Clin Endocrinol Metab. 2014;99(3):E453–7.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of Digestive, Hepato-Biliary and Endocrine SurgeryUniversity Hospital Nancy BraboisVandoeuvre-Les-NancyFrance
  2. 2.Department of EndocrinologyUniversity Hospital Nancy BraboisVandoeuvre-Les-NancyFrance
  3. 3.Department of RhumatologyUniversity Hospital Nancy BraboisVandoeuvre-Les-NancyFrance
  4. 4.Department of PathologyUniversity Hospital Nancy BraboisVandoeuvre-Les-NancyFrance

Personalised recommendations